| Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma DJ Glazar, GD Grass, JA Arrington, PA Forsyth, N Raghunand, HHM Yu, ... Journal of Clinical Medicine 9 (7), 2019, 2020 | 20 | 2020 |
| Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab DJ Glazar, M Johnson, J Farinhas, CE Steuer, NF Saba, M Bonomi, ... Oral Oncology 127, 105787, 2022 | 10 | 2022 |
| Re: Simulation analysis for tumor radiotherapy based on three‐component mathematical models MC Ferrall‐Fairbanks, DJ Glazar, RJ Brady, GJ Kimmel, MU Zahid, ... Journal of applied clinical medical physics 20 (7), 204, 2019 | 1 | 2019 |
| COMP-13. EARLY TUMOR VOLUME EVOLUTION ADAPTIVELY PREDICTS PATIENT-SPECIFIC RESPONSE AND PROGRESSION RISK TO RADIOTHERAPY, PEMBROLIZUMAB, AND BEVACIZUMAB IN RECURRENT HIGH-GRADE … D Glazar, R Brady, R Howard, D Grass, J Arrington, M Yu, N Raghunand, ... Neuro-Oncology 21 (Suppl 6), vi63, 2019 | | 2019 |
| Proliferation Saturation Index to Prospectively Predict Patient-Specific Responses to Radiation in Oropharyngeal Cancer M Zahid, D Glazar, R Brady, EG Moros, LB Harrison, JJ Caudell, ... International Journal of Radiation Oncology• Biology• Physics 105 (1), E792, 2019 | | 2019 |
